Literature DB >> 7991991

pH-dependent LAK cell cytotoxicity.

T Severin1, B Müller, G Giese, B Uhl, B Wolf, S Hauschildt, W Kreutz.   

Abstract

In the microenvironment of many solid tumors the pH is considerably lower (mean pH between 6.6 to 7.2) than the pH in normal tissue (pH 7.0-7.5). Therefore, the influence of acidic pH on the cytotoxic activity of lymphokine-activated killer cells (LAK cells) after different culture periods was tested. K-562 human erythroleukemia cells were selected as target cells. Cell killing was measured using a two-color flow cytometric method. At physiological pH of 7.4, LAK cell-mediated cytotoxicity ranged from 15 to 48% (E:T ratio = 50:1). The specific lysis of target cells was considerably reduced (up to 70% inhibition of specific lysis) under acidic conditions (pH 6.8, 6.3, 5.8). This effect was independent of donors, duration of the culture period, and the E:T ratio in the cytotoxic assay. As pH gradients surrounding tumor cells may reach values below pH 6.0 at the cell surface, the pH-dependence of LAK cell cytotoxicity could at least partially explain the inhibition of the natural immune response in solid tumors. Therapeutic immunological strategies concerning the enhancement of the natural immune response like LAK cell and IL-2 immunotherapy including IL-2 gene therapy may only be successful if a simultaneous inhibition of the acidification process and an elevation of tumor pH is achieved.

Entities:  

Mesh:

Year:  1994        PMID: 7991991     DOI: 10.1159/000217905

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  12 in total

Review 1.  [Microsensory systems in cell biology basic research and medical diagnostics].

Authors:  M Brischwein; W Baumann; R Ehret; A Schwinde; M Kraus; B Wolf
Journal:  Naturwissenschaften       Date:  1996-05

Review 2.  The acidic microenvironment as a possible niche of dormant tumor cells.

Authors:  Silvia Peppicelli; Elena Andreucci; Jessica Ruzzolini; Anna Laurenzana; Francesca Margheri; Gabriella Fibbi; Mario Del Rosso; Francesca Bianchini; Lido Calorini
Journal:  Cell Mol Life Sci       Date:  2017-03-22       Impact factor: 9.261

3.  An acidic microenvironment impairs the generation of non-major histocompatibility complex-restricted killer cells.

Authors:  B Müller; B Fischer; W Kreutz
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

Review 4.  Can Exercise-Induced Modulation of the Tumor Physiologic Microenvironment Improve Antitumor Immunity?

Authors:  Xiaojie Zhang; Kathleen A Ashcraft; Allison Betof Warner; Smita K Nair; Mark W Dewhirst
Journal:  Cancer Res       Date:  2019-05-08       Impact factor: 12.701

Review 5.  Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry.

Authors:  Elena Andreucci; Silvia Peppicelli; Jessica Ruzzolini; Francesca Bianchini; Lido Calorini
Journal:  Cancer Metastasis Rev       Date:  2022-10-13       Impact factor: 9.237

6.  Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head-Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy.

Authors:  Ioannis M Koukourakis; Anastasia G Gkegka; Erasmia Xanthopoulou; Christos Nanos; Alexandra Giatromanolaki; Michael I Koukourakis
Journal:  Curr Oncol       Date:  2022-06-15       Impact factor: 3.109

Review 7.  Can 'permissive' hypercapnia modulate the severity of sepsis-induced ALI/ARDS?

Authors:  Gerard Curley; Mairead Hayes; John G Laffey
Journal:  Crit Care       Date:  2011-03-22       Impact factor: 9.097

Review 8.  Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy.

Authors:  Yiliang Li; Sapna Pradyuman Patel; Jason Roszik; Yong Qin
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

Review 9.  Science review: extracellular acidosis and the immune response: clinical and physiologic implications.

Authors:  John A Kellum; Mingchen Song; Jinyou Li
Journal:  Crit Care       Date:  2004-06-16       Impact factor: 9.097

Review 10.  Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs--an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research.

Authors:  Salvador Harguindey; Jose Luis Arranz; Julian David Polo Orozco; Cyril Rauch; Stefano Fais; Rosa Angela Cardone; Stephan J Reshkin
Journal:  J Transl Med       Date:  2013-11-06       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.